Healthcare provider profile · identity verified

Shabnam Moshref, D.O.

Internal Medicine · INDIANAPOLIS, IN · NPI 1275844102

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	747	216
Levothyroxine Sodium	Levothyroxine Sodium	490	132
Amlodipine Besylate	Amlodipine Besylate	463	141
Lisinopril	Lisinopril	409	114
Omeprazole	Omeprazole	370	107
Metoprolol Succinate	Metoprolol Succinate	328	88
Rosuvastatin Calcium	Rosuvastatin Calcium	315	100
Losartan Potassium	Losartan Potassium	289	84
Gabapentin	Gabapentin	266	67
Metformin Hcl Er	Metformin Hcl	259	68
Simvastatin	Simvastatin	209	58
Glipizide Er	Glipizide	207	50
Alendronate Sodium	Alendronate Sodium	204	71
Pantoprazole Sodium	Pantoprazole Sodium	196	54
Hydrochlorothiazide	Hydrochlorothiazide	183	50
Montelukast Sodium	Montelukast Sodium	176	44
Fluoxetine Hcl	Fluoxetine Hcl	168	41
Fluticasone Propionate	Fluticasone Propionate	165	64
Metformin Hcl	Metformin Hcl	163	54
Duloxetine Hcl	Duloxetine Hcl	158	36
Mounjaro	Tirzepatide	153	30
Allopurinol	Allopurinol	142	32
Venlafaxine Hcl Er	Venlafaxine Hcl	127	23
Tramadol Hcl	Tramadol Hcl	126	28
Albuterol Sulfate Hfa	Albuterol Sulfate	121	46
Ezetimibe	Ezetimibe	116	32
Jardiance	Empagliflozin	116	31
Trazodone Hcl	Trazodone Hcl	115	33
Famotidine	Famotidine	114	36
Pravastatin Sodium	Pravastatin Sodium	109	34
Furosemide	Furosemide	100	34
Ozempic	Semaglutide	98	22
Trulicity	Dulaglutide	92	18
Sertraline Hcl	Sertraline Hcl	90	28
Buspirone Hcl	Buspirone Hcl	86	28
Citalopram Hbr	Citalopram Hydrobromide	86	21
Synthroid	Levothyroxine Sodium	85	22
Potassium Chloride	Potassium Chloride	83	25
Tamsulosin Hcl	Tamsulosin Hcl	74	20
Valsartan	Valsartan	72	20
Escitalopram Oxalate	Escitalopram Oxalate	69	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	68	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	66	19
Metoprolol Tartrate	Metoprolol Tartrate	65	22
Clopidogrel	Clopidogrel Bisulfate	64	20
Shingrix	Varicella-Zoster Ge/As01b/Pf	64	56
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	20
Bupropion Xl	Bupropion Hcl	60	21
Eliquis	Apixaban	56	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	55	14
Atenolol	Atenolol	54	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	54	13
Fenofibrate	Fenofibrate Nanocrystallized	52	13
Irbesartan	Irbesartan	50	15
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	49	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	48	15
Amitriptyline Hcl	Amitriptyline Hcl	47	14
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	43	42
Carvedilol	Carvedilol	42	11
Januvia	Sitagliptin Phosphate	42	13
Mirtazapine	Mirtazapine	42	14
Glimepiride	Glimepiride	41	12
Esomeprazole Magnesium	Esomeprazole Magnesium	39	11
Ropinirole Hcl	Ropinirole Hcl	38	13
Ipratropium Bromide	Ipratropium Bromide	35	13
Meloxicam	Meloxicam	35	16
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Tresiba Flextouch U-200	Insulin Degludec	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	25
Diclofenac Sodium	Diclofenac Sodium	29	15
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	29	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	28	28
Doxycycline Hyclate	Doxycycline Hyclate	28	26
Nystatin	Nystatin	28	12
Prednisone	Prednisone	28	22
Torsemide	Torsemide	28	suppressed
Topiramate	Topiramate	27	suppressed
Ventolin Hfa	Albuterol Sulfate	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	25	suppressed
Telmisartan	Telmisartan	25	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Clobetasol Propionate	Clobetasol Propionate	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Fluconazole	Fluconazole	24	20
Insulin Lispro Kwikpen U-100	Insulin Lispro	24	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	24	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	16
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Aripiprazole	Aripiprazole	22	suppressed
Humalog Kwikpen U-100	Insulin Lispro	22	suppressed
Tradjenta	Linagliptin	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Finasteride	Finasteride	21	suppressed
Labetalol Hcl	Labetalol Hcl	21	suppressed
Verapamil Sr	Verapamil Hcl	21	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	20	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	20	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Baclofen	Baclofen	19	suppressed
Colestipol Hcl	Colestipol Hcl	19	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Ketoconazole	Ketoconazole	19	13
Meclizine Hcl	Meclizine Hcl	18	13
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Alprazolam	Alprazolam	16	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Repatha Sureclick	Evolocumab	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Klayesta	Nystatin	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Clonidine	Clonidine	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Ondansetron Odt	Ondansetron	11	11
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed
Zonisamide	Zonisamide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error